Kronos Bio Stock Quote KRON - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.9175

Bid

0.90

Ask

0.99

Volume

137,679

0.9031 Day's Range 0.9525

0.69 52 Week Range 1.60

Market Cap

55.363M

Previous Close

0.95

Open

0.95

Last Trade

595

0.9175

Last Trade Time

16:00:00

Financial Volume

$ 126,570

VWAP

0.919312

Average Volume (3m)

239,754

Shares Outstanding

60,340,918

Dividend Yield

PE Ratio

-0.49

Earnings Per Share (EPS)

-1.87

Revenue

6.29M

Net Profit

-112.67M

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kronosbio.com

Headquarters

Wilmington, Delaware, USA

Founded

Kronos Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KRON. The last closing price for Kronos Bio was $0.95. Over the last year, Kronos Bio shares have traded in a share price range of $ 0.69 to $ 1.60.

Kronos Bio currently has 60,340,918 shares outstanding. The market capitalization of Kronos Bio is $57.32 million. Kronos Bio has a price to earnings ratio (PE ratio) of -0.49.

California Biotech Stock Bid Up Prior To Opening Bell On Major Announcement

A California-based biotech company is already stealing the show during Wednesday’s premarket after the company announced a CEO transition...

Kronos Bio Announces CEO Transition and Reduction in Force

– Norbert Bischofberger, Ph.D., is stepping down from his role as President & CEO – – Deborah Knobelman...

Form EFFECT - Notice of Effectiveness

Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024

– Preclinical data demonstrate the ability of p300 KAT inhibition to modulate multiple pro-inflammatory...

Form 8-K - Current report

Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives

– Discontinuing development of istisociclib, a CDK9 inhibitor; benefit-risk profile in platinum-resistant...

Form S-3 - Registration statement under Securities Act of 1933

Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma

– Data demonstrates Kronos Bio's approach to targeting oncogenic transcription factors and the strong...

Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors

SAN MATEO, Calif., and CAMBRIDGE, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0075	-0.810810810811	0.925	0.989999	0.9031	197661	0.95377859	CS
4	-0.0325	-3.42105263158	0.95	1.04	0.9031	180678	0.97934547	CS
12	-0.0325	-3.42105263158	0.95	1.07	0.8902	239754	0.97014082	CS
26	-0.0625	-6.37755102041	0.98	1.09	0.8	205420	0.95512413	CS
52	-0.4325	-32.037037037	1.35	1.6	0.69	270567	1.01981081	CS
156	-6.3225	-87.3273480663	7.24	8.42	0.69	290076	2.12900784	CS
260	-27.3725	-96.7568045246	28.29	39.605	0.69	278084	7.96452241	CS

KRON - Frequently Asked Questions (FAQ)

What is the current Kronos Bio share price?

The current share price of Kronos Bio is $ 0.9175

How many Kronos Bio shares are in issue?

Kronos Bio has 60,340,918 shares in issue

What is the market cap of Kronos Bio?

The market capitalisation of Kronos Bio is USD 57.32M

What is the 1 year trading range for Kronos Bio share price?

Kronos Bio has traded in the range of $ 0.69 to $ 1.60 during the past year

What is the PE ratio of Kronos Bio?

The price to earnings ratio of Kronos Bio is -0.49

What is the cash to sales ratio of Kronos Bio?

The cash to sales ratio of Kronos Bio is 8.83

What is the reporting currency for Kronos Bio?

Kronos Bio reports financial results in USD

What is the latest annual turnover for Kronos Bio?

The latest annual turnover of Kronos Bio is USD 6.29M

What is the latest annual profit for Kronos Bio?

The latest annual profit of Kronos Bio is USD -112.67M

What is the registered address of Kronos Bio?

The registered address for Kronos Bio is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Kronos Bio website address?

The website address for Kronos Bio is www.kronosbio.com

Which industry sector does Kronos Bio operate in?

Kronos Bio operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
HCTIHealthcare Triangle Inc	$ 0.5857 (80.22%)	8.8M
SSPEW Scripps Company	$ 1.79 (25.17%)	102.8k
SMSISmith Micro Software Inc	$ 1.30 (20.93%)	922.75k
SFIXStitch Fix Inc	$ 5.06 (19.62%)	1.7M
ONEGOneConstruction Group Limited	$ 2.65 (17.78%)	789
HEPAHepion Pharmaceuticals Inc	$ 0.053 (-36.90%)	11.93M
CUTRCutera Inc	$ 0.091 (-15.66%)	1.71M
WCTWellchange Holdings Company Limited	$ 0.6201 (-13.25%)	563.8k
AUUDAuddia Inc	$ 0.2801 (-11.67%)	187.43k
VYGRVoyager Therapeutics Inc	$ 3.5777 (-9.88%)	13.73k
HEPAHepion Pharmaceuticals Inc	$ 0.053 (-36.90%)	11.93M
HCTIHealthcare Triangle Inc	$ 0.5857 (80.22%)	8.8M
NVDANVIDIA Corporation	$ 108.4306 (-0.30%)	3.59M
STISolidion Technology Inc	$ 0.1367 (8.41%)	2.88M
AMDAdvanced Micro Devices Inc	$ 96.65 (-0.11%)	2.87M